Effects of Switching from Anti-VEGF Treatment to Triamcinolone Acetonide in Eyes with Refractory Macular Edema Associated with Diabetic Retinopathy or Retinal Vein Occlusion

PURPOSE: To evaluate the efficacy of switching from intravitreal antivascular endothelial growth factor (VEGF) agents to triamcinolone acetonide (TA) in eyes with diabetic macular edema (DME) or with retinal vein occlusion-associated macular edema (RVO-ME) on the resolution of the macular edema (ME)...

Descripción completa

Detalles Bibliográficos
Autores principales: Tatsumi, Tomoaki, Oshitari, Toshiyuki, Baba, Takayuki, Takatsuna, Yoko, Yamamoto, Shuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695504/
https://www.ncbi.nlm.nih.gov/pubmed/33274211
http://dx.doi.org/10.1155/2020/4529850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695504/
https://www.ncbi.nlm.nih.gov/pubmed/33274211
http://dx.doi.org/10.1155/2020/4529850

Ejemplares similares